• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global osteoarthritis therapeutics market grew at a CAGR of around 8% during 2014-2019. Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown. Looking forward, IMARC Group expects the global osteoarthritis therapeutics market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, anatomy type, drug type, route of administration and end user.

Breakup by Anatomy Type:

  • Knee
  • Hip
  • Hand
  • Spine
  • Others
     

Breakup by Drug Type:

  • Nonsteroidal Anti-Inflammatory Drugs
  • Analgesics
  • Corticosteroids
  • Others
     

Breakup by Route of Administration:

  • Parenteral
  • Topical
  • Oral
     

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Medical Institutions
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the anatomy type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global osteoarthritis therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Osteoarthritis Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Anatomy Type
    6.1    Knee
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Hip
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Hand
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Spine
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Drug Type
    7.1    Nonsteroidal Anti-Inflammatory Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Analgesics
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Corticosteroids
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Route of Administration
    8.1    Parenteral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Topical
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Oral
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Specialty Clinics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Medical Institutions    
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Anika Therapeutics Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials 
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer Aktiengesellschaft
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials 
           15.3.3.4 SWOT Analysis
        15.3.4    Eli Lilly and Company
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
           15.3.4.4 SWOT Analysis
        15.3.5    Flexion Therapeutics Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials 
        15.3.6    GlaxoSmithKline Plc
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Horizon Therapeutics Plc
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Johnson & Johnson Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanofi S.A
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2019
Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2019
Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2019
Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by End User (in %), 2019
Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2019
Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Global: Osteoarthritis Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Global: Osteoarthritis Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million US$), 2020-2025
Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2020-2025
Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by End User (in Million US$), 2020-2025
Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Osteoarthritis Therapeutics Market Structure
Table 8: Global: Osteoarthritis Therapeutics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links